New Action: First Group of SENATE Leaders to Contact!

by Heather on November 6, 2017

Thank you for all the calls, faxes and tweets made to House Leadership! Now we are turning our focus to the Senate.

This week, November 6th-9th, we ask all members to contact the following Senate leadership offices:

Majority Leader, Senator Mitch McConnell:
phone (202) 224-2541 — fax (202) 224-2499 — Twitter @McConnellPress

Minority Leader, Senator Chuck Schumer:
phone (202) 228-3027 — fax (202) 226-2019 — Twitter @SenSchumer

Finance Committee Chairman, Senator Orrin Hatch:
phone (202) 224-5251 — fax (202) 224-6331 — Twitter @SenOrrinHatch

 
Finance Committee Ranking Member, Senator Ron Wyden:
phone (202) 224-5244 — fax (202) 228-2717 — Twitter @RonWyden
Here is what you do:
Call, fax or tweet the offices listed above. A script is provided for phone calls. For faxing, use our ready-to-go
fax form. If tweeting, simply copy and paste our pre-set message. Choose your method or feel free to use
them all. Please ask your friends and family to reach out as well– the more participation, the greater the impact.

Phone script:
“Please tell Senator [name] to pass the Lymphedema Treatment Act (S497) this year. With over 325 cosponsors, this bipartisan and bicameral bill is one of the most widely supported health care bills in Congress. Millions of Americans with lymphedema – the majority of them cancer survivors – are counting on Senator [name] to modernize Medicare and close this coverage gap.”

Fax form (GoogleDocs):
Version 1 – download as a Word doc, complete then print.
Version 2 – print then complete by hand.

Twitter message:
Please pass @LymphedemaAct now! bipart/bicam 325 cosponsors! Millions—mostly cancer survivors—need coverage gap fix @HHSGov

The plan:
If you missed contacting any of the House Leaders their information is below. Also, feel free to contact any office multiple times.

Together, we can pass the LTA!

Heather Ferguson
Founder & Executive Director
Lymphedema Advocacy Group
LymphedemaTreatmentAct.org

Previous post:

Next post: